Aphex BioCleanse Systems, Inc. (‘Aphex’ or ‘the Company’) announced that interim CEO and Chairman of the Board, Tony Fedor have resigned from their roles, allowing for the Company to pursue a renewed focus on seeking regulatory approval and operational excellence in the Bio Life Sciences markets.